Equity Analysis

Quarterly Results

    Dr Reddys Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500124
    INE089A01023
    1453.1267897
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DRREDDY
    22.28
    96742.08
    EPS(TTM)
    Face Value()
    Div & Yield %:
    260.28
    5
    0.69
     
Quarters
(RupeeIcon Cr)
ParticularsMar 2024Dec 2023Sep 2023
Gross Sales5081.804083.104819.10
Other Operating Income23.0019.9019.60
Other Income 212.70227.60223.10
Total Income5317.504330.605061.80
Total Expenditure 3726.203446.703209.60
PBIDT1591.30883.901852.20
Interest 5.905.605.80
PBDT1585.40878.301846.40
Depreciation246.20246.40245.80
Tax270.20156.90396.00
Fringe Benefit Tax0.000.000.00
Deferred Tax34.20-0.2012.00
Reported Profit After Tax1034.80475.201192.60
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item1034.80475.201192.60
EPS (Unit Curr.)62.1428.5571.68
EPS (Adj) (Unit Curr.)62.1428.5571.68
Calculated EPS (Unit Curr.)62.0428.4971.50
Calculated EPS (Adj) (Unit Curr.)62.0428.4971.50
Calculated EPS (Ann.) (Unit Curr.)248.15113.96286.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)248.15113.96286.00
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity83.4083.4083.40
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)31.3121.6538.43
PBDTM(%)31.2021.5138.31
PATM(%)20.3611.6424.75
Dividend Per Share(Rs)0.000.000.00
Diluted EPS62.0428.5071.54